lithorex-B in ureteral stones

Phase 3

Recruiting

Conditions: ureteral stone.
Calculus of ureter
N20.1

Registration Number: IRCT20200822048478N1

Lead Sponsor: Kashan University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 102

Inclusion Criteria

ureteral stone diameter less than 10 mm
age over 18

Exclusion Criteria

Pregnancy and lactation
Taking drugs that affect kidney stones
azotemia
active UTI
severe cardiovascular or respiratory disease
The need for immediate intervention to remove the stone
surgical treatment candidate
taking diuretic drugs
taking calcium
gastrointestinal bleeding
hypersensitivity reaction
Itching, skin rash and contact dermatitis
History of allergy to salicylates
Coagulopathy
Nasal polyps and asthma

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of stone excretion. Timepoint: The duration of the study is 4 weeks. Individuals will be followed up weekly during the study period. Follow-up of patients at the beginning and end of the study will be clinical and at the end of the first, second and third weeks by telephone. Method of measurement: Use of a checklist that includes: clinical examination, interview with the patient and the result of ultrasound.;Stone diameter. Timepoint: The duration of the study is 4 weeks. Individuals will be followed up weekly during the study period. Follow-up of patients at the beginning and end of the study will be clinical and at the end of the first, second and third weeks by telephone. Method of measurement: Use of a checklist that includes: clinical examination, interview with the patient and the result of ultrasound.

Secondary Outcome Measures

Name	Time	Method
Possible side effects. Timepoint: The duration of the study is 4 weeks. Individuals will be followed up weekly during the study period. Follow-up of patients at the beginning and end of the study will be clinical and at the end of the first, second and third weeks by telephone. Method of measurement: Use of a checklist that includes: clinical examination, interview with the patient and the result of ultrasound.;Pain. Timepoint: The duration of the study is 4 weeks. Individuals will be followed up weekly during the study period. Follow-up of patients at the beginning and end of the study will be clinical and at the end of the first, second and third weeks by telephone. Method of measurement: Use of a checklist that includes: clinical examination, interview with the patient and the result of ultrasound.